Abstract:Objectives: The objectives of this study were to screen lactic acid bacteria (LAB) that can produce angiotensin-converting enzyme (ACE) inhibitory peptides and to evaluate their probiotic properties. Methods: Lactic acid bacteria were inoculated into skimmed milk, the proteolysis degree and ACE inhibition rate of fermented milk were determined by colorimetric assays. Two LAB (ZJUIDS09 and ZJUIDS11) that resulted in the highest proteolysis degree and ACE inhibition rate were selected, and their probiotic properties were evaluated, including acid resistance, bile salt resistance, antibiotic resistance, and antibacterial activity. The fermented milk produced by the two strains was treated with simulated gastrointestinal digestive juices, and their ACE inhibition rates were determined. Finally, the two strains were used as starter cultures in the fermentation of Holstein skim milk, Holstein whey, buffalo skim milk and buffalo whey, and the ACE inhibition rates of the fermented milk were determined. Results: The degrees of proteolysis of fermented milk produced by strain ZJUIDS09 and ZJUIDS11 were 5.79%±0.14% and 5.75%±0.10%, respectively. Their ACE inhibition rates were 87.39%±2.44% and 90.41%±0.99%, respectively. And their IC50 were 0.36 and 0.27 mg/mL, respectively. Their ACE inhibition rates after digestion with simulated gastrointestinal juices were decreased to 70.13%±0.15% and 76.39%±2.91%, respectively. Strains ZJUIDS09 and ZJUIDS11 were resistant to acid and bile salt, exhibited antibacterial activity and antibiotic sensitivity, and were identified as Lactobacillus reuteri and Lactobacillus helveticus by 16S rRNA. Comparing Holstein skim milk, Holstein whey, Buffalo skim milk and Buffalo whey after strain fermentation, Holstein skim milk was the most suitable substrates for strains ZJUIDS09 and ZJUIDS11 to produce ACE-inhibitory peptides. Conclusion: Lactobacillus reuteri ZJUIDS09 and Lactobacillus helveticus ZJUIDS11 screened in this study had a strong ability to produce ACE inhibitory peptides and had the potential to develop fermented dairy products with blood pressure-lowering effect.

Optimization of Nutrient Composition for Producing ACE Inhibitory Peptides from Goat Milk Fermented by Lactobacillus bulgaricus LB6

Studies on Preparation of ACE Inhibitory Peptides Through Hydrolyzing of Casein by Enzymatic Membrane Reactor

Optimization of Fermentation Conditions for the Production of Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides from Cow Milk by Lactobacillus bulgaricus LB6

Production and Fermentation Characteristics of Angiotensin-I-converting Enzyme Inhibitory Peptides of Goat Milk Fermented by a Novel Wild Lactobacillus Plantarum 69

ACE Inhibitory and Antioxidant Peptides from Alcalase‐assisted Lactiplantibacillus Plantarum L60 and Lacticaseibacillus Rhamnosus LR22 Fermentation of Goat Milk: Optimization and Identification

Production of Angiotensin I-Converting Enzyme Inhibitory Peptide from Goat Milk Casein: Optimization Conditions of Complex Protease Hydrolysate by Response Surface Methodology and Purification

Optimization of Sour Milk Fermentation for the Production of ACE-inhibitory Peptides and Purification of a Novel Peptide from Whey Protein Hydrolysate

Purification and Identification of Novel Peptides with Inhibitory Effect Against Angiotensin I-Converting Enzyme and Optimization of Process Conditions in Milk Fermented with the Yeast Kluyveromyces Marxianus

Collaborative optimization and molecular docking exploration of novel ACE-inhibitory peptides from bovine milk by complex proteases hydrolysis

Identification and In Silico Analysis of ACE-Inhibitory Peptides Derived from Milk Fermented by Lacticaseibacillus paracasei

Studies on the Preparation of ACE Inhibitory Peptides from Enzymic Hydrolysate of Milk Casein

Directed‐Vat‐Set Starter Producing ACE ‐inhibitory Peptides: Optimization and Evaluation of Stability

Novel Angiotensin-Converting Enzyme-Inhibitory Peptides from Fermented Bovine Milk Started by Lactobacillus Helveticus KLDS.31 and Lactobacillus Casei KLDS.105: Purification, Identification, and Interaction Mechanisms

Optimization of Enzymatic Hydrolysis Technology of Casein by Proteinases from Lactobacillus Helveticus for ACE Inhibitory Peptide Production

Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus

Enrichment of ACE Inhibitory Peptides in Navy Bean (phaseolus Vulgaris) Using Lactic Acid Bacteria.

Screening, Probiotic Properties Evaluation and Application of ACE-inhibitory Peptide-producing Lactic Acid Bacteria

Optimizing Fermentation Conditions of Lactobacillus helveticus for Preparing ACE Inhibitory Peptides from Whey Protein

Antioxidant Peptides from Goat Milk Fermented by Lactobacillus casei L61: Preparation, Optimization, and Stability Evaluation in Simulated Gastrointestinal Fluid

Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria

Proteomics Analysis of Proteolytic System Expression of Lactic Acid Bacteria in Fermented Goat Milk with ACE Inhibitory Potential